Axel Prévot

Research Intern | Mines Paris & Institut Curie Centre for Computational Biology lab at Mines Paris
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Paris, Île-de-France, France, FR

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • MOOC Gestion de Projet, Attestation session 12 Parcours Avancé
    MOOC Gestion de Projet
    Dec, 2018
    - Oct, 2024

Experience

  • Mines Paris
    • France
    • Higher Education
    • 300 - 400 Employee
    • Research Intern | Mines Paris & Institut Curie Centre for Computational Biology lab
      • Apr 2022 - Present

      The Centre for Computational Biology (CBIO) is a research center of Mines ParisTech and focuses on Machine Learning approaches applied to biological and medical data. The CBIO has a partnership with the Institut Curie and INSERM and is part of a mixed unit INSERM U900: Bioinformatics and Computational Systems Biology of Cancer. Advisor: Florian Massip, PhD The Centre for Computational Biology (CBIO) is a research center of Mines ParisTech and focuses on Machine Learning approaches applied to biological and medical data. The CBIO has a partnership with the Institut Curie and INSERM and is part of a mixed unit INSERM U900: Bioinformatics and Computational Systems Biology of Cancer. Advisor: Florian Massip, PhD

  • INSERM
    • France
    • Research Services
    • 700 & Above Employee
    • Co-founder/Director of MemiR
      • Sep 2021 - Present

      Design, creation and administration of the "MemiR" tool in collaboration with the INSERM U892 Cancer Research Centre. MemiR is a platform of bioinformatics tools aimed at predicting the presence of different types of methylations affecting miRNAs (MemiRPred), the impact that these methylations could have on the structure and exosomal export of miRNAs (MemiRStruct and MemiRExo) but also on the presence of therapeutic options (miR4TO) and/or resistance to anti-cancer therapies (miR4Resist). https://memir.shinyapps.io/MemiR/ Show less

  • ENGIE South East Asia
    • Singapore
    • Utilities
    • 300 - 400 Employee
    • Strategy and M&A analyst intern
      • Mar 2021 - Aug 2021

      Valuated societies of interest observed for acquisition Built business plans to evaluate the viability of a potential acquistion – developed VBA tools Analyzed markets of Green Mobility in the area Valuated societies of interest observed for acquisition Built business plans to evaluate the viability of a potential acquistion – developed VBA tools Analyzed markets of Green Mobility in the area

  • EY
    • United Kingdom
    • IT Services and IT Consulting
    • 700 & Above Employee
    • Auditor
      • Sep 2020 - Feb 2021

      Audit of "mid-cap" company accounts (Meero, Kuehne Nagel, Buffet Crampon, ProWebce...). Adapted to short audit cycles: multiplicity of engagements, frequent changes of team and client Developed VBA/Python automation tools Audit of "mid-cap" company accounts (Meero, Kuehne Nagel, Buffet Crampon, ProWebce...). Adapted to short audit cycles: multiplicity of engagements, frequent changes of team and client Developed VBA/Python automation tools

  • Amazon
    • United States
    • Software Development
    • 700 & Above Employee
    • Student Brand Ambassador
      • Sep 2019 - Apr 2020

      Promoted the worldwide "Prime Student" program on Lille student campuses. Enrolled 1,200 people in the offer over 3 months, the program's European record. Developed a tool for monitoring enrolments. Promoted the worldwide "Prime Student" program on Lille student campuses. Enrolled 1,200 people in the offer over 3 months, the program's European record. Developed a tool for monitoring enrolments.

Education

  • Ecole centrale de Nantes
    2021 - 2022
  • Centrale Lille
    Diplôme d'ingénieur, Sciences
    2018 - 2021
  • Collège Stanislas Paris
    Preparatory classes
    2016 - 2018

Community

You need to have a working account to view this content. Click here to join now